NIH-funded research U01 cooperative agreement

Increasing the use of HIV prevention medication.

Official title: RFA-PS-21-003: PrEP Choice: Increasing the Use of HIV Pre-exposure Prophylaxis in an Era of Choices

Funded at Florida State University · NIH-10843030 · Data updated 2026-11-12

This study is all about making it easier for people at risk of HIV to access and use PrEP, a medication that helps prevent HIV, by finding out what stops them from using it and creating helpful programs to encourage informed choices about it.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionFlorida State University
NIH-funded
Lab location1 site (Tallahassee, United States)
Project startOctober 26, 2022
Project endSeptember 29, 2026
Funding year2024
Award (this year)$1,040,000
NIH project number5U01PS005246-03
Project IDNIH-10843030 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at high risk for HIV who are considering preventive options.

Less likely to help

Patients who are not at risk for HIV or those who are already using PrEP may not receive additional benefits from this research.

What this research studies

This research focuses on enhancing the accessibility and utilization of HIV pre-exposure prophylaxis (PrEP) among individuals at risk of HIV infection. It aims to identify barriers to PrEP uptake and develop strategies to promote informed decision-making regarding its use. By engaging with communities and healthcare providers, the research seeks to create tailored interventions that encourage more people to consider and use PrEP as a preventive measure against HIV. The methodology may include surveys, educational programs, and outreach initiatives to raise awareness and support for PrEP.

Why it matters

Potential benefit: If successful, this research could significantly increase the number of individuals using PrEP, thereby reducing the incidence of HIV infections.

How similar studies have gone: Previous research has shown that targeted interventions can effectively increase PrEP uptake, indicating a promising approach for this study.

Where this research is happening

  • Florida State University
    Tallahassee, United States
    Active

Researchers

  • Principal investigator: Hightow-Weidman, Lisa B — Florida State University
  • Study coordinator: Hightow-Weidman, Lisa B

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.